Sildenafil (Viagra) has demonstrated cardioprotective effects, showing an improvement in heart function without any adverse effect on blood pressure, according to results published in BMC Medicine.
Italian researchers led by Andrea Isidori, MD, PhD, of the Department of Experimental Medicine at the Sapienza University of Rome observed 1,622 patients, with 954 who were randomized to the drug and 772 on placebo.
“We found that the main ingredient in Viagra can be used as an effective, safe treatment for several patients with heart disease,” Dr. Isidori stated.
Additionally, Viagra was shown to prevent left ventricular hypertrophy, a precursor to heart failure that thickens the heart’s main pumping chamber. The PDE5i chemical prevented the heart from increasing in size and changing shape. Therefore, the authors stated that the drug could be safely administered to men who suffer from early-stage heart failure.
“Large clinical trials are now urgently needed to build on these encouraging findings,” Dr. Isidori concluded. Further research is required in order to understand the effect of Viagra on women with related heart conditions.
Viagra demonstrated improvement in heart function without any adverse effect on blood pressure.
Viagra could provide a treatment for heart disease as well as problems in the bedroom, a study suggests. In trials, the impotency pill’s active ingredient improved the heart performance of patients with a range of conditions while having no adverse effect on blood pressure.
Most importantly, it helped prevent harmful thickening of the heart’s main pumping chamber caused by the organ having to work too hard. The condition, known as left ventricular hypertrophy, can lead to heart failure, an inability to pump blood around the body.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.
From Metro
